Search Results - "MARROQUIN, Carlos E"

Refine Results
  1. 1

    Patient Selection for Kidney Transplant by Marroquin, Carlos E., MD

    Published in The Surgical clinics of North America (01-02-2019)
    “…The incidence of end-stage renal disease has continued to increase. Similarly, the number of patients living with a functioning renal allograft has also…”
    Get full text
    Journal Article
  2. 2

    Predictive indices of morbidity and mortality after liver resection by SCHROEDER, Rebecca A, MARROQUIN, Carlos E, BUTE, Barbara Phillips, KHURI, Shukri, HENDERSON, William G, KUO, Paul C

    Published in Annals of surgery (01-03-2006)
    “…To determine if use of Model for End-Stage Liver Disease (MELD) scores to elective resections accurately predicts short-term morbidity or mortality. MELD…”
    Get full text
    Journal Article
  3. 3

    Resection of Noncolorectal Nonneuroendocrine Liver Metastases: A Comparative Analysis by Reddy, Srinevas K., MD, Barbas, Andrew S., BS, Marroquin, Carlos E., MD, Morse, Michael A., MD, Kuo, Paul C., MD, MBA, FACS, Clary, Bryan M., MD, FACS

    “…Background Although established for metastatic colorectal (CR) and neuroendocrine (NE) malignancies, the role of partial hepatectomy in management of…”
    Get full text
    Journal Article
  4. 4

    Extended hepatic resection for gallbladder cancer by Reddy, Srinevas K., M.D, Marroquin, Carlos E., M.D, Kuo, Paul C., M.D., M.B.A, Pappas, Theodore N., M.D, Clary, Bryan M., M.D

    Published in The American journal of surgery (01-09-2007)
    “…Abstract Background Although radical cholecystectomy is the standard of care for gallbladder cancers that invade perimuscular connective tissue or perforate…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Endovascular Treatment of Venous Outflow and Portal Venous Complications After Liver Transplantation by Aaberg, Michael T, Marroquin, Carlos E, Kokabi, Nima, Bhave, Anant D, Shields, Joseph T, Majdalany, Bill S

    “…Liver transplantation continues to rapidly evolve, and in 2020, 8906 orthotopic liver transplants were performed in the United States. As a technically complex…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Increased risk organ transplantation in the pediatric population by Wrenn, Sean M., Callas, Peter W., Kapoor, Trishul, Aunchman, Alia F., Paine, Adam N., Pineda, Jaime A., Marroquin, Carlos E.

    Published in Pediatric transplantation (01-12-2017)
    “…IRD organs are classified by the Public Health Service to be at above‐average risk for harboring human immunodeficiency virus, hepatitis C, and hepatitis B…”
    Get full text
    Journal Article
  9. 9

    Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis by Wai, Philip Y., Mi, Zhiyong, Guo, Hongtao, Sarraf-Yazdi, Shiva, Gao, Chengjiang, Wei, Junping, Marroquin, Carlos E., Clary, Bryan, Kuo, Paul C.

    Published in Carcinogenesis (New York) (01-04-2005)
    “…Hepatic metastasis is a primary cause for failure of locoregional therapy in colorectal cancer. Increased expression of osteopontin (OPN), a ligand for αvβ3…”
    Get full text
    Journal Article
  10. 10

    Relationship Between Provider Volume and Outcomes For Orthotopic Liver Transplantation by Scarborough, John E., Pietrobon, Ricardo, Tuttle-Newhall, Janet E., Marroquin, Carlos E., Collins, Bradley H., Desai, Dev M., Kuo, Paul C., Pappas, Theodore N.

    Published in Journal of gastrointestinal surgery (01-09-2008)
    “…Introduction Recent data suggests that the previously demonstrable relationship between hospital volume and outcomes for liver transplant procedures may no…”
    Get full text
    Journal Article
  11. 11

    Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells by Marroquin, Carlos E., Downey, Laura, Guo, Hongtao, Kuo, Paul C.

    Published in Immunology letters (15-08-2004)
    “…Background: Osteopontin (OPN) is an inducible cell attachment protein which binds α vβ 3-integrin and CD44 receptors to promote tumor metastasis. We…”
    Get full text
    Journal Article
  12. 12

    Transplantation of hepatitis C–positive livers in hepatitis C–positive patients is equivalent to transplanting hepatitis C–negative livers by Marroquin, Carlos E., Marino, Gustavo, Kuo, Paul C., Plotkin, Jeffrey S., Rustgi, Vinod K., Lu, Amy D., Edwards, Erick, Taranto, Sarah, Johnson, Lynt B.

    Published in Liver transplantation (01-09-2001)
    “…A significant number of patients with end-stage liver disease secondary to hepatitis C die of disease-related complications. Liver transplantation offers the…”
    Get full text
    Journal Article
  13. 13

    Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells by HONGTAO GUO, MARROQUIN, Carlos E, WAI, Philip Y, KUO, Paul C

    Published in Digestive diseases and sciences (01-07-2005)
    “…Our objective was to delineate the role of nitric oxide (NO) in osteopontin (OPN)-associated metastatic properties in HepG2 cells. OPN is the major…”
    Get full text
    Journal Article
  14. 14

    Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States by Scarborough, John E, Pietrobon, Ricardo, Marroquin, Carlos E, Tuttle-Newhall, Janet E, Kuo, Paul C, Collins, Bradley H, Desai, Dev M, Pappas, Theodore N

    Published in Journal of gastrointestinal surgery (01-01-2007)
    “…Procedures such as liver transplantation, which entail large costs while benefiting only a small percentage of the population, are being increasingly…”
    Get full text
    Journal Article
  15. 15

    Mobilization of dendritic cell precursors in patients with cancer by Flt3 ligand allows the generation of higher yields of cultured dendritic cells by MARROQUIN, Carlos E, WESTWOOD, Jennifer A, LAPOINTE, Rejean, MIXON, Arnold, WUNDERLICH, John R, CARON, Dania, ROSENBERG, Steven A, HWU, Patrick

    Published in Journal of immunotherapy (1997) (01-05-2002)
    “…Flt3 ligand (Flt3L) stimulates the proliferation and differentiation of hematopoietic cells. Subcutaneous Flt3L administration has been shown to effectively…”
    Get full text
    Journal Article
  16. 16

    Temporal trends in liver transplant centre volume in the USA by Tracy, Elisabeth T., Bennett, Kyla M., Aviki, Emeline M., Pappas, Theodore N., Collins, Bradley H., Tuttle-Newhall, Janet E., Marroquin, Carlos E., Kuo, Paul C., Scarborough, John E.

    Published in HPB (Oxford, England) (01-08-2009)
    “…Although prior studies have suggested an inverse association between liver transplant centre volume and postoperative patient mortality, more recent analyses…”
    Get full text
    Journal Article
  17. 17

    Half-life analysis of pancreas and kidney transplants by MARROQUIN, Carlos E, EDWARDS, Erick B, COLLINS, Bradley H, DESAI, Dev M, TUTTLE-NEWHALL, Janet E, KUO, Paul C

    Published in Transplantation (27-07-2005)
    “…Although graft and patient survival data are available for pancreas and kidney transplants, they are rarely reported in terms of half-life. Our aim was to…”
    Get full text
    Journal Article
  18. 18

    Tolerance and the “Holy Grail” of transplantation by Schroeder, Rebecca A, Marroquin, Carlos E, Kuo, Paul C

    Published in The Journal of surgical research (01-05-2003)
    “…Advances in transplantation biology have greatly improved patient outcomes following transplant surgery. However, generalized immunosuppression remains the…”
    Get full text
    Journal Article
  19. 19

    Redox-mediated upregulation of hepatocyte iNOS transcription requires coactivator PC4 by Marroquin, Carlos E., Wai, Philip Y., Kuo, Paul C., Guo, Hongtao

    Published in Surgery (01-07-2005)
    “…Redox-mediated upregulation of transcription of hepatocyte inducible nitric oxide synthase (iNOS) requires hepatocyte nuclear factor IV-alpha (HNF-4α). In this…”
    Get full text
    Journal Article Conference Proceeding
  20. 20